Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.
Najibah A Galadanci,Shehu U Abdullahi, Shehi Ali Abubakar,Binta Wudil Jibir,Hauwa Aminu,Aliyu Tijjani,Muhammad S Abba,Musa A Tabari,Aisha Galadanci,Awwal Musa Borodo,Raymond Belonwu,Auwal S Salihu,Mark Rodeghier,Djamila L Ghafuri,Brittany V Covert C Greene,Kathleen Neville,Adetola A Kassim,Fenella J Kirkham,Lori C Jordan,Muktar H Aliyu,Michael R DeBaun American journal of hematology（2020）
AI 理解论文
溯源树
样例
